Show simple item record

dc.contributor.authorBryant, Curtis M
dc.contributor.authorHenderson, Randal H
dc.contributor.authorNichols, R Charles
dc.contributor.authorMendenhall, William M
dc.contributor.authorHoppe, Bradford S
dc.contributor.authorVargas, Carlos E
dc.contributor.authorDaniels, Thomas B
dc.contributor.authorChoo, C Richard
dc.contributor.authorParikh, Rahul R
dc.contributor.authorGiap, Huan
dc.contributor.authorSlater, Jerry D
dc.contributor.authorVapiwala, Neha
dc.contributor.authorBarrett, William
dc.contributor.authorNanda, Akash
dc.contributor.authorMishra, Mark V
dc.contributor.authorChoi, Seungtaek
dc.contributor.authorLiao, Jay J
dc.contributor.authorMendenhall, Nancy P
dc.date.accessioned2021-11-03T18:52:51Z
dc.date.available2021-11-03T18:52:51Z
dc.date.issued2021-04-12
dc.identifier.urihttp://hdl.handle.net/10713/17058
dc.description.abstractProton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding its value. Multiple prospective and retrospective studies have been published documenting the efficacy and safety of proton therapy for patients with localized prostate cancer and for patients requiring adjuvant or salvage pelvic radiation after surgery. The Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee intends to address current proton therapy indications, advantages, disadvantages, and cost effectiveness. We will also discuss the current landscape of clinical trials. This consensus report can be used to guide clinical practice and research directions.en_US
dc.description.urihttps://doi.org/10.14338/IJPT-20-00031.1en_US
dc.description.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/pmc8489490/
dc.language.isoenen_US
dc.publisherInternational Journal of Particle Therapyen_US
dc.relation.ispartofInternational Journal of Particle Therapyen_US
dc.rights©Copyright 2021 The Author(s).en_US
dc.subjectparticle therapyen_US
dc.subjectprostate canceren_US
dc.subjectproton therapyen_US
dc.subjectradiation therapyen_US
dc.titleConsensus Statement on Proton Therapy for Prostate Canceren_US
dc.typeArticleen_US
dc.identifier.doi10.14338/IJPT-20-00031.1
dc.identifier.pmid34722807
dc.source.volume8
dc.source.issue2
dc.source.beginpage1
dc.source.endpage16
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record